Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease

American Journal of Cardiology

Volumn 96, Issue 5, 2005, Pages 655-658

  Vu, John D ^a   Vu, Jack B ^a   Pio, Jose R ^a   Malik, Shaista ^a   Franklin, Stanley S ^a   Chen, Roland S ^b   Wong, Nathan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUTRITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLIC HEALTH; TIME SERIES ANALYSIS; UNITED STATES;

ADULT; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEPHELOMETRY AND TURBIDIMETRY; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 23944451554     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.038     Document Type: Article

References (21)

1. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, T.J. McCaan, D. Browner Mortality over 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
2. G. Brevetti, V.D. Martone, S. Perna, F. Cacciatore, S. Corrado, A. DiDonato, A. DiIorio Intermittent claudication and risk of cardiovascular events Angiology 49 1998 843 848
3. P.M. Ridker, M.J. Stampfer, N. Rifai Novel risk factors for systemic atherosclerosis a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
4. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
5. J.K. Olijhoek, Y. van der Graaf, J.D. Banga, A. Algra, T.J. Rabelink, F.L. Visseren SMART Study Group The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm Eur Heart J 25 2004 342 348
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
7. Third National Health and Nutrition Examination Survey. Anthropometry Procedures Manual, Revised December 2000. Available at http://www.cdc.gov/nchs/ data/nhanes/bm.pdf. Accessed in December 2000.
8. D. Perloff, C. Grim, J. Flack, E.D. Froelich, M. Hill, M. McDonald, B.Z. Morgenstern Human blood pressure determination by sphygmomanometry Circulation 88 1993 2460 2469
9. J.I. Weitz, J. Byrne, G.P. Clagett, M.E. Farkouk, J.M. Porter, D.L. Sackett, D.E. Strandness Jr, L.M. Taylor Diagnosis and treatment of chronic arterial insufficiency of the lower extremities a critical review Circulation 94 1996 3026 3049
10. NHANES 1999-2000 Laboratory/Medical Technologists Procedures Manual.
11. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon III, M. Criqui, Y.Y. Fadl, S.P. Fortman, Y. Hong, G.L. Myers Centers for Disease Control and Prevention and the American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
12. S. Malik, N.D. Wong, S.S. Franklin, J. Pio, C. Fairchild, R. Chen Risk of cardiovascular disease in U.S. persons with metabolic syndrome, diabetes and elevated C-reactive protein Diabet Care 28 2005 690 693
13. M.H. Criqui, D. Browner, A. Fronek, M.R. Klauber, S.S. Coughlin, E. Barrett-Connor, S. Gabriel Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease an analysis of risk factors Am J Epidemiol 129 1989 1110 1119
14. M.H. Criqui, R.D. Langer, A. Fronek Larger vessel and isolated small vessel disease F.G.R. Fowkes Epidemiology of Peripheral Vascular Disease 1991 Springer-Verlag London
15. F.G. Fowkes, E. Housely, R.A. Riermersma, C.C. Macintyre, E.H. Cawood, R.J. Drescott, C.V. Ruckley Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study Am J Epidemiol 135 1992 331 340
16. H.I. Yu, W.H. Sheu, Y.M. Song, H.C. Liu, W.J. Lee, Y.T. Chen C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus Diabet Med 21 2004 336 341
17. P.M. Gorter, J.K. Olijhoek, Y. van der Graaf, A. Algra, T.J. Ravelink, F.L. Visseren SMART Study Group Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm Atherosclerosis 173 2004 361 367
18. L.A. Costa, L.H. Canani, H.R. Lisboa, G.S. Tres, J.L. Gross Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes Diabet Med 21 2004 252 255
19. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
20. P.M. Ridker, N. Rifai, M.A. Pfeffer, F.M. Sacks, L.A. Moye, S. Goldman, G.C. Flaker, E. Braunwald Cholesterol and Recurrent Events (CARE) Investigators Inflammation, pravastatin, and risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
21. M.M. McDermott, D. Green, P. Greenland, K. Liu, M.H. Criqui, C. Chan, J.M. Garalnik, W.H. Pearce, P.M. Ridker, L. Taylor, N. Rifai, J.R. Schneider Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index Am J Cardiol 92 2003 194 199